MQS Management LLC Buys New Holdings in Stryker Corporation (NYSE:SYK)

MQS Management LLC purchased a new position in Stryker Corporation (NYSE:SYK - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,533 shares of the medical technology company's stock, valued at approximately $943,000. Stryker makes up 0.5% of MQS Management LLC's investment portfolio, making the stock its 15th biggest position.

A number of other institutional investors have also recently bought and sold shares of the stock. Norges Bank purchased a new position in Stryker during the 4th quarter valued at about $1,710,744,000. GAMMA Investing LLC grew its stake in Stryker by 43,226.8% during the 1st quarter. GAMMA Investing LLC now owns 2,074,922 shares of the medical technology company's stock valued at $772,390,000 after acquiring an additional 2,070,133 shares in the last quarter. FMR LLC grew its stake in Stryker by 10.0% during the 4th quarter. FMR LLC now owns 8,034,844 shares of the medical technology company's stock valued at $2,892,946,000 after acquiring an additional 727,850 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in Stryker during the 4th quarter valued at about $154,140,000. Finally, Northern Trust Corp grew its stake in Stryker by 13.2% during the 4th quarter. Northern Trust Corp now owns 3,606,237 shares of the medical technology company's stock valued at $1,298,426,000 after acquiring an additional 420,153 shares in the last quarter. Hedge funds and other institutional investors own 77.09% of the company's stock.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the transaction, the director directly owned 3,417,326 shares in the company, valued at $1,288,195,208.96. The trade was a 5.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several equities analysts have weighed in on SYK shares. Sanford C. Bernstein set a $450.00 target price on Stryker in a research note on Monday, May 5th. Roth Mkm boosted their price target on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. Wall Street Zen cut Stryker from a "buy" rating to a "hold" rating in a research note on Friday, June 27th. Evercore ISI boosted their price target on Stryker from $390.00 to $415.00 and gave the company an "outperform" rating in a research note on Tuesday, July 8th. Finally, JMP Securities reissued a "market perform" rating on shares of Stryker in a research note on Monday, May 5th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Stryker has a consensus rating of "Moderate Buy" and an average price target of $428.55.

Stryker Stock Performance

Stryker stock traded down $5.53 during trading hours on Friday, reaching $389.24. 825,133 shares of the company were exchanged, compared to its average volume of 1,354,569. The firm has a market cap of $148.57 billion, a price-to-earnings ratio of 52.60, a PEG ratio of 2.94 and a beta of 0.91. The company has a current ratio of 1.64, a quick ratio of 1.00 and a debt-to-equity ratio of 0.69. The stock has a 50-day moving average of $384.79 and a 200 day moving average of $377.14. Stryker Corporation has a 12 month low of $314.93 and a 12 month high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company had revenue of $5.87 billion during the quarter, compared to analyst estimates of $5.68 billion. During the same period in the previous year, the company earned $2.50 earnings per share. The company's quarterly revenue was up 11.9% compared to the same quarter last year. As a group, research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be issued a dividend of $0.84 per share. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.86%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.